NYSE · traded in Congress
Merck & Company, MRK
$148.5287 +1.7987 (+1.23%) Nov 9, 2026 4:29 AM ET
Market value$366.2B
P/E ratio-
Analyst target$165.00
52-week range-
Avg volume8,553,358
Dividend yield-
Chart
Analyst ratings
- 21 buy
- 8 hold
- 1 sell
Low target$105.00
Average target$162.96
High target$186.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $18,085M | - | $5,065M | 28.0% | |
| $16,607M | - | $-1,335M | -8.0% | |
| $16,286M | - | $-4,240M | -26.0% | |
| $16,400M | - | $2,963M | 18.1% |
Congress trades in MRK
Members of Congress disclosed 3 transactions in MRK in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/24/2026 | Maria Elvira Salazar FL27 | Partial sale | $1,001 - $15,000 | 10/7/2026 filing |
| 08/19/2026 | Maria Elvira Salazar FL27 | Purchase | $15,001 - $50,000 | 9/9/2026 filing |
| 08/19/2026 | Maria Elvira Salazar FL27 | Purchase | $15,001 - $50,000 | 9/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
